Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives

Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives

Genetic and environmental factors play important roles in cancer progression, metastasis, and drug resistance. Herein, we used a multiomics data analysis to evaluate the predictive and prognostic roles of genetic and epigenetic modulation of c-MET (hepatocyte growth factor receptor)/epidermal growth...

Full description

Bibliographic Details
Main Authors:	Bashir Lawal, Yu-Chi Wang, Alexander T. H. Wu, Hsu-Shan Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Pharmacology
Subjects:	colorectal cancer genetic and epigenetic alterations cancer-associated fibroblast immune infiltration small molecule NSC777205
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.691234/full

Similar Items

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
by: Bashir Lawal, et al.
Published: (2021-03-01)

Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule
by: Bashir Lawal, et al.
Published: (2022-05-01)

Structure-based design, synthesis and biological evaluation of N-substituted 6H-thiochromeno[2,3–c]quinolin-12(12H)-one as potential breast cancer drugs
by: Maryam Rachmawati Sumitra, et al.
Published: (2024-01-01)

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent
by: Harold A. Chinyama, et al.
Published: (2023-11-01)

HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses
by: Jih-Chin Lee, et al.
Published: (2020-12-01)

In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates
by: Bashir Lawal, et al.
Published: (2023-05-01)

Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects
by: Tse-Hung Huang, et al.
Published: (2021-08-01)

Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of <i>CCND1</i>/<i>CDK4</i>/<i>PLK1</i>/<i>CD44</i> in Cancer Types
by: Ntlotlang Mokgautsi, et al.
Published: (2021-05-01)

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential <em>GSK3β</em>/<em>β-Catenin</em>/<em>STAT3</em>/<em>CD44</em> Suppressor with Anti-Glioblastoma Properties
by: Ntlotlang Mokgautsi, et al.
Published: (2021-02-01)

Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration
by: Bashir Lawal, et al.
Published: (2021-10-01)

In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer
by: Lung-Ching Chen, et al.
Published: (2023-07-01)

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
by: Bashir Lawal, et al.
Published: (2021-01-01)

Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer
by: Ntlotlang Mokgautsi, et al.
Published: (2023-01-01)

A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling
by: Alexander T. H. Wu, et al.
Published: (2021-09-01)

Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis
by: Harshita Nivrutti Khedkar, et al.
Published: (2023-06-01)

4-Methyl-2H-1,3-oxazine-2,6(3H)-dione
by: Damon Parrish, et al.
Published: (2009-10-01)

4,5-Dichloro-2H-1,3-oxazine-2,6(3H)-dione
by: Damon Parrish, et al.
Published: (2009-10-01)

6-Allyl-8-methoxy-3-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazine
by: Jing Zhu, et al.
Published: (2011-08-01)

Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation
by: Vijesh Kumar Yadav, et al.
Published: (2020-06-01)

Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures
by: Ntlotlang Mokgautsi, et al.
Published: (2023-01-01)

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
by: Ntlotlang Mokgautsi, et al.
Published: (2022-01-01)

Synthesis and characterization of new 3,4-dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives
by: Gabbas, A. U. Garin, et al.
Published: (2016)

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
by: Harshita Nivrutti Khedkar, et al.
Published: (2021-05-01)

(Z)-4-(Carbomethoxymethylene)-2-(4-fluorophenyl)-4H-benzo[d][1,3]oxazine
by: Francesco Pancrazzi, et al.
Published: (2017-01-01)

Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer
by: Bashir Lawal, et al.
Published: (2023-07-01)

Structure-based strategies for synthesis, lead optimization and biological evaluation of N-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as potential multi-target anticancer agents
by: Ahmed Atef Ahmed Ali, et al.
Published: (2021-02-01)

Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
by: Abdelfattah Hassan, et al.
Published: (2023-12-01)

8,9-Isopropylidenedioxy-3-p-tolyl-1,6-dioxa-3-azaspiro[4.5]decane-2,10-dione
by: Chun-Sheng Ling, et al.
Published: (2008-11-01)

Crystal structure of 1,5-bis(4-methoxyphenyl)-1,4-pentadien-3-one, C19H18O3
by: Shan Y., et al.
Published: (1999-09-01)

One-pot syntheses of blue-luminescent 4-aryl-1H-benzo[f]isoindole-1,3(2H)-diones by T3P® activation of 3-arylpropiolic acids
by: Melanie Denißen, et al.
Published: (2017-11-01)

Crystal structure of bis(R-(+)-1-phenylethylammonium)tetraaqua-trioxolatodiferrate,[C6H5CH(CH3)NH3]2[Fe2(C2O4)3(H2O)4]
by: Shan Y., et al.
Published: (2001-04-01)

A Convenient One-pot Synthesis of 2,3-Disubstituted Thieno[2,3-d]pyrimidin-4(3H)-ones from 2H-Thieno[2,3-d][1,3]oxazine-2,4(1H)-diones, Aromatic Aldehydes and Amines
by: Feize Liu, et al.
Published: (2018-04-01)

Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan
by: Chih-Hsuan Su, et al.
Published: (2023-08-01)

Green and efficient synthesis of 1,2-bis(2H-benzo[e][1,3]oxazin-3(4H)-yl)ethanes and 1,2-bis(2H-benzo[e][1,3]thiazin-3(4H)-yl)ethanes
by: R.L. Nongkhlaw, et al.
Published: (2019-05-01)

Using 3D bioprinting to produce mini-brain
by: Hao-Wei Han, et al.
Published: (2017-01-01)

Crystal structure of 2-butyl-6-(ethylamino)-1H-benzo[de]isoquinoline-1,3(2H)-dione, C18H20N2O2
by: Liu Peilian, et al.
Published: (2019-12-01)

Crystal structure of 3,5-dihydroxybenzoic acid [1-(2-hydroxy-3- methoxyphenyl)methylidene]hydrazide — methanol — water (1:1:1), (C15H14N2O) · CH3OH · H2O
by: Huang Shan-Shan, et al.
Published: (2008-06-01)

Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody
by: Huang L, et al.
Published: (2020-08-01)

Organocatalytic Regio- and Enantioselective (3+3)-Annulation of 2-(4H-Benzo[d][1,3]oxazin-4-yl)acrylates with 2,4-Dihydro-3H-pyrazol-3-ones
by: Zhongyue Lu, et al.
Published: (2023-12-01)

3-Methyl-1-(3-nitrophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole
by: Jun-qiang Chen, et al.
Published: (2009-09-01)